{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:48:15Z","timestamp":1783226895279,"version":"3.54.6"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,3,1]]},"DOI":"10.1038\/sj.bmt.1702180","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:44:36Z","timestamp":1031154276000},"page":"525-531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis"],"prefix":"10.1038","volume":"25","author":[{"given":"T","family":"Koz\u00e1k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Havrdov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pit'ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Gregora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pytl\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Maaloufov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Mare\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Kobylka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160","family":"Vodv\u00e1\u0159kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,3,9]]},"reference":[{"key":"BF1702180_CR1","first-page":"733","volume":"83","author":"AM Marmont","year":"1998","unstructured":"Marmont AM . Stem cell transplantation for severe autoimmune diseases. Progress and problems Haematologica 1998 83: 733\u2013743","journal-title":"Haematologica"},{"key":"BF1702180_CR2","first-page":"13","volume":"24","author":"AM Marmont","year":"1997","unstructured":"Marmont AM . Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases J Rheumatol 1997 24: (Suppl. 48) 13\u201318","journal-title":"J Rheumatol"},{"key":"BF1702180_CR3","first-page":"85","volume":"12","author":"S Slavin","year":"1993","unstructured":"Slavin S . Treatment of life threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT BoneMarrow Transplant 1993 12: 85\u201388","journal-title":"BoneMarrow Transplant"},{"key":"BF1702180_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2141.1997.3273144.x","volume":"99","author":"JA Snowden","year":"1997","unstructured":"Snowden JA, Brooks PM, Boggs JC . Haematopoietic stem cell transplantation for autoimmune diseases Br J Haematol 1997 99: 9\u201323","journal-title":"Br J Haematol"},{"key":"BF1702180_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.bmt.1700727","volume":"19","author":"A Tyndall","year":"1997","unstructured":"Tyndall A, Grathwohl A . Blood and marrow stem cell transplants in autoimmune disease: a consensus report written on behalf of the EULAR and EBMT Bone Marrow Transplant 1997 19: 643\u2013645","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR6","first-page":"pp 129","volume-title":"Multiple Sclerosis","author":"JF Hallpike","year":"1983","unstructured":"Hallpike, JF . Clinical aspects of multiple sclerosis. In: Hallpike JF, Adams CWM, Tourtellotte WW (eds) Multiple Sclerosis Chapman and Hall: London 1983 pp 129\u2013161"},{"key":"BF1702180_CR7","first-page":"pp 45","volume-title":"Frontiers in Multiple Sclerosis","author":"HP Hartung","year":"1997","unstructured":"Hartung HP . Pathogenesis of multiple sclerosis. In: Abramsky O, Ovadia H (eds) Frontiers in Multiple Sclerosis Martin Dunitz: London 1997 pp 45\u201360"},{"key":"BF1702180_CR8","first-page":"810","volume":"43","author":"HL Weiner","year":"1993","unstructured":"Weiner HL, Mackin GA, Orav EJ et al. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group Neurology 1993 43: 810\u2013918","journal-title":"Neurology"},{"key":"BF1702180_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/jnnp.62.2.112","volume":"62","author":"G Edan","year":"1997","unstructured":"Edan G, Miller D, Clanet M et al. Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis J Neurol Neurosurg Psych 1997 62: 112\u2013118","journal-title":"J Neurol Neurosurg Psych"},{"key":"BF1702180_CR10","first-page":"S35 (Abstr. 108","volume":"23","author":"T Kozak","year":"1999","unstructured":"Kozak T, Gregora E, Havrdova E et al. High dose immunoablative chemotherapy with double T cell depletion in the treatment of multiple sclerosis Bone Marrow Transplant 1999 23: (Suppl. 1) S35 (Abstr. 108)","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR11","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 1983 33: 1444\u20131452","journal-title":"Neurology"},{"key":"BF1702180_CR12","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1212\/WNL.34.10.1368","volume":"34","author":"JC Sipe","year":"1984","unstructured":"Sipe JC, Knobler RL, Brahney SL et al. A neurologic rating scale (NRS) for use in multiple sclerosis Neurology 1984 34: 1368\u20131372","journal-title":"Neurology"},{"key":"BF1702180_CR13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.7326\/0003-4819-129-12-199812150-00007","volume":"129","author":"AR Brodsky","year":"1998","unstructured":"Brodsky AR, Petri M, Smith BD et al. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease Ann Intern Med 1998 129: 1031\u20131035","journal-title":"Ann Intern Med"},{"key":"BF1702180_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000040826","volume":"99","author":"S Ikehara","year":"1998","unstructured":"Ikehara S . Bone marrow transplantation for autoimmune diseases Acta Haematol 1998 99: 116\u2013132","journal-title":"Acta Haematol"},{"key":"BF1702180_CR15","first-page":"333","volume":"8","author":"S Knaan-Shanzer","year":"1991","unstructured":"Knaan-Shanzer S, Houben P, Bohre EPM et al. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation Bone Marrow Transplant 1991 8: 333\u2013338","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1172\/JCI116648","volume":"92","author":"DM Karussis","year":"1993","unstructured":"Karussis DM, Vourka-Karussis U, Lehmann D et al. Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation J Clin Invest 1993 92: 765\u2013772","journal-title":"J Clin Invest"},{"key":"BF1702180_CR17","first-page":"233","volume":"11","author":"M van Gelder","year":"1993","unstructured":"van Gelder M, Kinwel-Bohr\u00e9 EPM, van Bekkum DW . Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT Bone Marrow Transplant 1993 11: 233\u2013241","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/sj.bmt.1700666","volume":"19","author":"LD McAllister","year":"1997","unstructured":"McAllister LD, Beatty PG, Rose J . Allogeneic BMT for chronic myelogenous leukemia in a patient with multiple sclerosis. Case report Bone Marrow Transplant 1997 19: 395\u2013397","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR19","first-page":"31","volume":"9","author":"JA Liu Yin","year":"1992","unstructured":"Liu Yin JA, Jowitt SN . Resolution of immune-mediated diseases following allogeneic BMT for leukemia Bone Marrow Transplant 1992 9: 31\u201333","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR20","first-page":"S34 (Abstr. 106","volume":"23","author":"P Hentschke","year":"1999","unstructured":"Hentschke P, Fredrikson S, Lonqvist B et al. Allogeneic stem cell transplantation for CML in two patients with MS Bone Marrow Transplant 1999 23: (Suppl. 1) S34 (Abstr. 106)","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR21","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1182\/blood.V89.12.4659","volume":"89","author":"G Meloni","year":"1997","unstructured":"Meloni G, Capria S, Vignetti M, Mandelli F . Blast crisis of CML in long-lasting systemic lupus erythematosus: regression of both diseases after autologous BMT Blood 1997 89: 4659\u20134666","journal-title":"Blood"},{"key":"BF1702180_CR22","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/sj.bmt.1700815","volume":"19","author":"JA Snowden","year":"1997","unstructured":"Snowden JA, Patton WN, O'Donnell JL et al. Prolonged remission of longstanding lupus erythematosus after autologous BMT for non-Hodgkin's lymphoma Bone Marrow Transplant 1997 19: 1247\u20131250","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR23","first-page":"808 (Abstr. 206","volume":"84","author":"D Salzman","year":"1994","unstructured":"Salzman D, Tami J, Jackson C et al. Clinical remission of myasthenia gravis in patient after high-dose chemotherapy and autologous transplantation with CD34+ stem cells Blood 1994 84: (Suppl. 1) 808 (Abstr. 206a)","journal-title":"Blood"},{"key":"BF1702180_CR24","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/art.1780400923","volume":"40","author":"HM Cooley","year":"1997","unstructured":"Cooley HM, Snowden JA, Grigg A, Wicks IP . Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy Arthritis Rheum 1997 40: 1712\u20131715","journal-title":"Arthritis Rheum"},{"key":"BF1702180_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/clin.1998.4563","volume":"89","author":"DW van Bekkum","year":"1998","unstructured":"van Bekkum DW . New opportunities for the treatment of severe autoimmune diseases: bone marrow transplantation Clin Immunol Immunopathol 1998 89: 1\u201310","journal-title":"Clin Immunol Immunopathol"},{"key":"BF1702180_CR26","first-page":"183","volume":"11","author":"DW van Bekkum","year":"1993","unstructured":"van Bekkum DW . BMT in experimental autoimmune diseases Bone Marrow Transplant 1993 11: 183\u2013187","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR27","first-page":"497","volume":"16","author":"AM Marmont","year":"1995","unstructured":"Marmont AM, van Bekkum DW . Stem cell transplantation for severe autoimmune diseases: new proposals but still unanswered questions Bone Marrow Transplant 1995 16: 497\u2013498","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR28","first-page":"413","volume":"16","author":"J Storek","year":"1995","unstructured":"Storek J, Witherspoon RP, Storb R . T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life Bone Marrow Transplant 1995 16: 413\u2013425","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.bmt.1700944","volume":"20","author":"A Fassas","year":"1997","unstructured":"Fassas A, Anagnastopoulos A, Kazis A et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study Bone Marrow Transplant 1997 20: 631\u2013638","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR30","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V92.10.3505","volume":"92","author":"RK Burt","year":"1998","unstructured":"Burt RK, Traynor AE, Pope R et al. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation Blood 1998 92: 3505\u20133515","journal-title":"Blood"},{"key":"BF1702180_CR31","first-page":"831","volume":"26","author":"DW van Bekkum","year":"1998","unstructured":"van Bekkum DW . Autologous stem cell therapy for treatment of autoimmune diseases Exp Hematol 1998 26: 831\u2013834","journal-title":"Exp Hematol"},{"key":"BF1702180_CR32","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1182\/blood.V88.9.3621.bloodjournal8893621","volume":"88","author":"HH Euler","year":"1996","unstructured":"Euler HH, Marmont AM, Bacigalupo A . Early recurrence or persistence of autoimmune disease after unmanipulated autologous stem cell transplantation Blood 1996 88: 3621\u20133625","journal-title":"Blood"},{"key":"BF1702180_CR33","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/sj.bmt.1701431","volume":"22","author":"AM Marmont","year":"1998","unstructured":"Marmont AM, van Lint MT, Occhini D et al. Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura Bone Marrow Transplant 1998 22: 827\u2013828","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1046\/j.1365-2141.1997.3553169.x","volume":"99","author":"RC Skoda","year":"1997","unstructured":"Skoda RC, Tichelli A, Tyndall A et al. Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia Br J Haematol 1997 99: 56\u201357","journal-title":"Br J Haematol"},{"key":"BF1702180_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/sj.bmt.1700624","volume":"19","author":"G Koehne","year":"1997","unstructured":"Koehne G, Zeller W, Stockschlaeder M, Zander AR . Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation Bone Marrow Transplant 1997 19: 149\u2013156","journal-title":"Bone Marrow Transplant"},{"key":"BF1702180_CR36","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1182\/blood.V92.5.1471","volume":"92","author":"T Guillaume","year":"1998","unstructured":"Guillaume T, Rubinstein D, Symann M . Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation Blood 1998 92: 1471\u20131490","journal-title":"Blood"},{"key":"BF1702180_CR37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Kapelushnik Y et al. Nonmyeloablative stem cell transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases Blood 1998 91: 756\u2013763","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702180","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:51:24Z","timestamp":1648072284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,1]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,3,1]]}},"alternative-id":["BF1702180"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702180","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,1]]},"assertion":[{"value":"19 July 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}